Literature DB >> 3091684

High- and low-affinity interleukin 2 receptors: distinctive effects of monoclonal antibodies.

M Fujii, K Sugamura, S Nakai, Y Tanaka, H Tozawa, Y Hinuma.   

Abstract

We previously established several mouse hybridoma cell lines producing monoclonal antibodies against the human interleukin 2 (IL 2) receptor molecule. As they bind to both high- and low-affinity IL 2 receptors, their effects on binding of 125I-labeled IL 2 to high- and low-affinity receptors were examined by Scatchard plot analysis. Two of these monoclonal antibodies, HIEI and H-47, reduced the IL 2 binding affinity of high-affinity receptors from a Kd of 14 to 20 pM to a Kd of 110 to 140 pM, but slightly raised that of low-affinity receptors. These two antibodies scarcely affected the numbers of high- and low-affinity receptors. On the other hand, H-31 completely blocked IL 2 binding to both high- and low-affinity receptors, and H-A26 slightly reduced the affinities of both high- and low-affinity receptors, from 17 pM to 28 pM and from 28 nM to 54 nM, respectively. H-48 had little affect on IL 2 binding to high- or low-affinity receptors. By use of these monoclonal antibodies, the inhibitory effect of IL 2 on growth of an HTLV-I-immortalized T cell line was demonstrated to be transmitted from high-affinity, but not low-affinity, receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091684

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Human IFN-gamma up-regulates IL-2 receptors in mitogen-activated T lymphocytes.

Authors:  M A Rodriguez; J B De Sanctis; A M Blasini; M Leon-Ponte; I Abadi
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

2.  Structure-function relationships for the interleukin 2 receptor: location of ligand and antibody binding sites on the Tac receptor chain by mutational analysis.

Authors:  R J Robb; C M Rusk; M P Neeper
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  Characterization of interleukin 2-stimulated phosphorylation of 67 and 63 kDa proteins in human T-cells.

Authors:  T Ishii; M Kohno; M Nakamura; Y Hinuma; K Sugamura
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

4.  Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.

Authors:  T Takeshita; Y Goto; K Tada; K Nagata; H Asao; K Sugamura
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

Review 5.  Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis.

Authors:  Stanley L Cohan; Elisabeth B Lucassen; Meghan C Romba; Stefanie N Linch
Journal:  Biomedicines       Date:  2019-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.